Home » Topics » Regulatory

Regulatory
RSS

Switch OTCs for allergies to be introduced by Fujisawa

Oct. 17, 1997

Fujisawa launches new OTC product

Oct. 17, 1997

Nascobal introduced in U.S., licensed to Meda for Nordic countries

Oct. 15, 1997

FDA actively reviewing TOBI

Oct. 13, 1997

CellPro seeks new indication for CEPRATE SC System

Oct. 13, 1997

Oral desmopressin evaluated in bed-wetting children

Oct. 13, 1997

Antiproliferative activity of simvastatin demonstrated against human gliomas

Oct. 13, 1997

FDA approval granted for Carbatrol

Oct. 10, 1997

Nastech files IND for new formulation of buprenorphine

Oct. 10, 1997

TheraTech joins forces with Meiji and Sankyo to develop and market oxybutynin patch

Oct. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...